{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2012"],"data_sharing_plan":["IPD Sharing (as of May 2021): Yes\nDescription: Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer’s data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.\nURL: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests"],"condition":["Colorectal Cancer","Colorectal Neoplasms","BRAF mutado cáncer colorrectal metastásico","BRAF mutant metastatic colorectal cancer"],"disease":["Braf Mutado Cáncer Colorrectal Metastásico","Braf Mutant Metastatic Colorectal Cancer","Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2134540"],"location":["Canada","South Korea","Netherlands","Belgium","United States","Norway","Japan","Italy","France","Australia","Germany","Spain"],"study_start_month":["11"],"keyword":["BYL719","LGX818","PI3K inhibitor","V600","Open-label dose escalation","BRAF inhibitor","BRAF","KRAS","Cetuximab","EGFR","Metastatic colorectal cancer"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer","description":"This study will assess the safety and efficacy of LGX818 when combined with cetuximab or combined with cetuximab and BYL719 in patients with BRAF mutant metastatic colorectal cancer","dates":{"creation":"2012-11-15"},"accession":"2134540","cross_references":{"ClinicalTrials___gov":["NCT01719380"],"EU Clinical Trials Register":["2012-002138-35"]}}